Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - GENOCEA BIOSCIENCES, INC.ex322_cfo906cert.htm
EX-32.1 - EXHIBIT 32.1 - GENOCEA BIOSCIENCES, INC.ex321_ceo906cert.htm
EX-31.2 - EXHIBIT 31.2 - GENOCEA BIOSCIENCES, INC.ex312_cfo302cert.htm
EX-31.1 - EXHIBIT 31.1 - GENOCEA BIOSCIENCES, INC.ex311_ceo302cert.htm
EX-10.33 - EXHIBIT 10.33 - GENOCEA BIOSCIENCES, INC.ex1033_siberconsulting.htm
EX-10.32 - EXHIBIT 10.32 - GENOCEA BIOSCIENCES, INC.ex1032_oncovirredacted.htm
EX-10.31 - EXHIBIT 10.31 - GENOCEA BIOSCIENCES, INC.ex1031htgc_amend2.htm
EX-4.5 - EXHIBIT 4.5 - GENOCEA BIOSCIENCES, INC.ex45_q12018warrant.htm
10-K - 10-K - GENOCEA BIOSCIENCES, INC.gnca-20171231x10k.htm
Exhibit 23.1


Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)
Registration Statement (Form S-8 No. 333-194021) pertaining to the Amended and Restated 2007 Equity Incentive Plan and 2014 Equity Incentive Plan of Genocea Biosciences, Inc.,
(2)
Registration Statement (Form S-8 No. 333-197127) pertaining to the 2014 Employee Stock Purchase Plan of Genocea Biosciences, Inc.,
(3)
Registration Statement (Form S-3 No. 333-203981) of Genocea Biosciences, Inc., and
(4)
Registration Statement (Form S-8 No. 333-216183) pertaining to the 2014 Equity Incentive Plan of Genocea Biosciences, Inc.;


of our report dated February 16, 2018, with respect to the consolidated financial statements of Genocea Biosciences, Inc. included in this Annual Report (Form 10-K) of Genocea Biosciences, Inc. for the year ended December 31, 2017.
 
/s/ Ernst & Young LLP

Boston, Massachusetts
February 16, 2018